| Dr Robert James Zabel, DO | |
|
20520 Keokuk Ave, Suite 104, Lakeville, MN 55044-6002 | |
| (952) 469-5033 | |
| (952) 469-5069 |
| Full Name | Dr Robert James Zabel |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 29 Years |
| Location | 20520 Keokuk Ave, Lakeville, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649248162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 46910 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Dermatology Pa | 9234147232 | 2 |
News Archive
The National Institutes of Health, under the National Library of Medicine's program on data science research, has awarded $1.55 million to an interdisciplinary team lead by Luis Rocha, a professor of informatics and the director of the NSF-NRT complex networks and systems program at the Indiana University School of Informatics, Computing and Engineering.
A postgraduate researcher at the University of Hertfordshire has found that Alzheimer's Disease (AD) results in greater language impairments in more highly-educated than less learned patients.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received final approval from the U.S. Food and Drug Administration to manufacture and market Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).
Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel — called colorectal metachronous adenomas — in people who previously had colorectal polyps removed.
› Verified 2 days ago
| Entity Name | Center For Dermatology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467649939 PECOS PAC ID: 9234147232 Enrollment ID: O20060403000467 |
News Archive
The National Institutes of Health, under the National Library of Medicine's program on data science research, has awarded $1.55 million to an interdisciplinary team lead by Luis Rocha, a professor of informatics and the director of the NSF-NRT complex networks and systems program at the Indiana University School of Informatics, Computing and Engineering.
A postgraduate researcher at the University of Hertfordshire has found that Alzheimer's Disease (AD) results in greater language impairments in more highly-educated than less learned patients.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received final approval from the U.S. Food and Drug Administration to manufacture and market Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).
Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel — called colorectal metachronous adenomas — in people who previously had colorectal polyps removed.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert James Zabel, DO 20520 Keokuk Ave, Suite 104, Lakeville, MN 55044-6002 Ph: (952) 469-5033 | Dr Robert James Zabel, DO 20520 Keokuk Ave, Suite 104, Lakeville, MN 55044-6002 Ph: (952) 469-5033 |
News Archive
The National Institutes of Health, under the National Library of Medicine's program on data science research, has awarded $1.55 million to an interdisciplinary team lead by Luis Rocha, a professor of informatics and the director of the NSF-NRT complex networks and systems program at the Indiana University School of Informatics, Computing and Engineering.
A postgraduate researcher at the University of Hertfordshire has found that Alzheimer's Disease (AD) results in greater language impairments in more highly-educated than less learned patients.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received final approval from the U.S. Food and Drug Administration to manufacture and market Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).
Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel — called colorectal metachronous adenomas — in people who previously had colorectal polyps removed.
› Verified 2 days ago